- Home
- GLMD vs BJDX Comparison
GLMD vs BJDX Comparison
Compare GLMD & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- BJDX
- Stock Information
- Founded
- GLMD 2000
- BJDX 2015
- Country
- GLMD Israel
- BJDX United States
- Employees
- GLMD N/A
- BJDX N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- BJDX Medical Specialities
- Sector
- GLMD Health Care
- BJDX Health Care
- Exchange
- GLMD Nasdaq
- BJDX Nasdaq
- Market Cap
- GLMD 3.0M
- BJDX 2.9M
- IPO Year
- GLMD 2014
- BJDX 2021
- Fundamental
- Price
- GLMD $1.83
- BJDX $1.63
- Analyst Decision
- GLMD Hold
- BJDX
- Analyst Count
- GLMD 1
- BJDX 0
- Target Price
- GLMD N/A
- BJDX N/A
- AVG Volume (30 Days)
- GLMD 353.4K
- BJDX 2.1M
- Earning Date
- GLMD 05-22-2025
- BJDX 08-13-2025
- Dividend Yield
- GLMD N/A
- BJDX N/A
- EPS Growth
- GLMD N/A
- BJDX N/A
- EPS
- GLMD N/A
- BJDX N/A
- Revenue
- GLMD N/A
- BJDX N/A
- Revenue This Year
- GLMD N/A
- BJDX N/A
- Revenue Next Year
- GLMD N/A
- BJDX $55.56
- P/E Ratio
- GLMD N/A
- BJDX N/A
- Revenue Growth
- GLMD N/A
- BJDX N/A
- 52 Week Low
- GLMD $1.15
- BJDX $1.46
- 52 Week High
- GLMD $23.80
- BJDX $37.50
- Technical
- Relative Strength Index (RSI)
- GLMD 60.37
- BJDX 45.74
- Support Level
- GLMD $1.74
- BJDX $1.59
- Resistance Level
- GLMD $1.91
- BJDX $1.72
- Average True Range (ATR)
- GLMD 0.12
- BJDX 0.08
- MACD
- GLMD -0.00
- BJDX 0.01
- Stochastic Oscillator
- GLMD 71.95
- BJDX 54.05
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.